Spire Healthcare (UK) Performance
| SPI Stock | 208.00 1.00 0.48% |
Spire Healthcare has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.61, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Spire Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spire Healthcare is expected to be smaller as well. Spire Healthcare right now has a risk of 1.44%. Please validate Spire Healthcare maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to decide if Spire Healthcare will be following its existing price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Spire Healthcare Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Spire Healthcare is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Forward Dividend Yield 0.0111 | Payout Ratio 0.3239 | Forward Dividend Rate 0.02 | Ex Dividend Date 2025-05-22 |
1 | Spire Healthcare Reports Steady Performance and Strategic NHS Partnership - TipRanks | 05/13/2025 |
2 | REG - Spire Healthcare Grp - Holding in Company - TradingView | 06/23/2025 |
3 | Spire Healthcare Logs Lower H1 Profit Revenue Grows - | 07/31/2025 |
| Begin Period Cash Flow | 49.6 M | |
| Total Cashflows From Investing Activities | -99 M |
Spire |
Spire Healthcare Relative Risk vs. Return Landscape
If you would invest 20,113 in Spire Healthcare Group on May 9, 2025 and sell it today you would earn a total of 687.00 from holding Spire Healthcare Group or generate 3.42% return on investment over 90 days. Spire Healthcare Group is generating 0.0634% of daily returns and assumes 1.4371% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Spire, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Spire Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spire Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spire Healthcare Group, and traders can use it to determine the average amount a Spire Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0441
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SPI | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.44 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Spire Healthcare is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spire Healthcare by adding it to a well-diversified portfolio.
Spire Healthcare Fundamentals Growth
Spire Stock prices reflect investors' perceptions of the future prospects and financial health of Spire Healthcare, and Spire Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spire Stock performance.
| Return On Equity | 0.0257 | ||||
| Return On Asset | 0.0391 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 2.11 B | ||||
| Shares Outstanding | 402.37 M | ||||
| Price To Book | 1.13 X | ||||
| Price To Sales | 0.55 X | ||||
| Revenue | 1.51 B | ||||
| Gross Profit | 698.7 M | ||||
| EBITDA | 250.4 M | ||||
| Net Income | 25.4 M | ||||
| Total Debt | 1.28 B | ||||
| Book Value Per Share | 1.83 X | ||||
| Cash Flow From Operations | 235.7 M | ||||
| Earnings Per Share | 0.05 X | ||||
| Total Asset | 2.34 B | ||||
| Retained Earnings | (462.9 M) | ||||
About Spire Healthcare Performance
By analyzing Spire Healthcare's fundamental ratios, stakeholders can gain valuable insights into Spire Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spire Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spire Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spire Healthcare is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Spire Healthcare performance evaluation
Checking the ongoing alerts about Spire Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spire Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 36.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Spire Healthcare Logs Lower H1 Profit Revenue Grows - |
- Analyzing Spire Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spire Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Spire Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spire Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spire Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spire Healthcare's stock. These opinions can provide insight into Spire Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spire Stock analysis
When running Spire Healthcare's price analysis, check to measure Spire Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spire Healthcare is operating at the current time. Most of Spire Healthcare's value examination focuses on studying past and present price action to predict the probability of Spire Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spire Healthcare's price. Additionally, you may evaluate how the addition of Spire Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |